SLU-PP-332 | 60ct

SLU-PP-332 | 60ct

$90.00

A potent ERRα/β/γ pan-agonist engineered for advanced metabolic and mitochondrial research.
SLU-PP-332 is the compound serious labs reach for when studying energy expenditure,
oxidation signaling, and exercise-mimetic pathways.

Research Highlights

  • ≥99% purity — HPLC verified, batch-documented COA available
  • 250mcg per capsule | 60-count — precision dosing for repeatable protocols
  • Targets ERRα, ERRβ, ERRγ — full pan-agonist activity for broad metabolic pathway studies
  • U.S.-manufactured | same-day dispatch | tamper-evident, research-grade packaging
- +
Invoice Sent After Order

SLU-PP-332 | ERRα/β/γ Pan-Agonist — 250mcg × 60 Capsules

SLU-PP-332 represents one of the most compelling compounds in contemporary
metabolic research. As a selective pan-agonist of estrogen-related receptors alpha, beta,
and gamma (ERRα/β/γ), this compound has become a critical tool for researchers investigating
the molecular mechanisms of energy homeostasis, mitochondrial biogenesis, and lipid oxidation
signaling — processes that parallel the physiological adaptations observed with endurance exercise.

Research Applications

SLU-PP-332 is purpose-built for controlled in vitro research environments.
Its documented ERR agonist activity makes it particularly valuable in studies examining:

  • Mitochondrial biogenesis signaling — ERR activation has been shown in
    preclinical models to upregulate PGC-1α co-activator pathways, a key driver of mitochondrial
    proliferation and oxidative capacity.
  • Fat oxidation and metabolic flux — Research into ERRα modulation
    consistently implicates this receptor in the transcriptional regulation of fatty acid
    β-oxidation enzymes, making SLU-PP-332 an ideal probe compound for lipid metabolism studies.
  • Exercise-mimetic pathway analysis — Classified as an exercise mimetic
    in the research literature, SLU-PP-332 enables investigation of the downstream signaling
    cascades typically activated by aerobic conditioning — without confounding exercise variables.
  • ERR isoform selectivity studies — Pan-agonist activity across all three
    ERR subtypes allows researchers to interrogate isoform-specific vs. shared transcriptional
    programs in a single experimental model.

Product Specifications

Attribute Details
Compound SLU-PP-332
Classification ERRα/β/γ Pan-Agonist | Exercise Mimetic
Dosage per Capsule 250mcg
Quantity 60 Capsules
Purity ≥99% | HPLC Verified
Format Oral Capsule
Origin U.S. Manufactured
Intended Use In Vitro / Laboratory Research Only
COA Available Upon Request

Why Bandit Research

Every batch of SLU-PP-332 shipped by Bandit Research is manufactured under strict quality
control standards and verified at ≥99% purity. Certificate of Analysis documentation is
available for every lot. We maintain consistent inventory of high-demand compounds — no
waitlists, no substitutions, no gaps in your research timeline. U.S.-based fulfillment
with same-day dispatch on orders placed before 2PM EST.

Research Use Only: SLU-PP-332 is intended exclusively for
in vitro laboratory research. Not for human or animal consumption,
diagnostic application, or therapeutic use. Not FDA-approved. Researchers are
responsible for ensuring full compliance with all applicable institutional,
federal, and local regulations prior to use.

Reviews

There are no reviews yet.

Be the first to review “SLU-PP-332 | 60ct”

Your email address will not be published. Required fields are marked *

SLU-PP-332 | 60ctSLU-PP-332 | 60ct
$90.00
- +
Scroll to Top